topotecan has been researched along with laurenditerpenol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruick, RK; Hossain, CF; Mohammed, KA; Nagle, DG; Zhang, L; Zhou, YD | 1 |
1 other study(ies) available for topotecan and laurenditerpenol
Article | Year |
---|---|
Laurenditerpenol, a new diterpene from the tropical marine alga Laurenciaintricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Diterpenes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mitochondria; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Rhodophyta; Stereoisomerism; Transcription Factors | 2004 |